COPDPredict

Exacerbation Prediction

Published by: NEPESMO

Description

COPDPredict is a CE-marked smart digital monitoring solution from NEPeSMO that allows individuals living with chronic obstructive airways disease (COPD) and their healthcare team to predict the onset of exacerbations (otherwise known as acute episodes or flare-ups) and prompt early intervention, thus preventing unnecessary emergency department visits and hospitalisations.
COPDPredict™ is for use by individuals with a diagnosis of COPD with greater than or equal to 1 acute exacerbation of their COPD per year.
COPDPredict™ allows you to input, collect, log and track trend data from blue-tooth connected suitable devices such as lung monitors in a home setting to share with a healthcare provider by sending data to a secure clinician-facing website.
COPDPredict™ uses a combination of your-reported wellbeing scores, lung function and biomarker levels to generate your own personal health profile. Exacerbation prediction algorithms determine the potential risk of an exacerbation of COPD based on your data inputs. Your healthcare team can then provide you with the tailored support and intervention you require closer to home. You can also communicate regularly and securely with your healthcare team using the within-App messaging facility.
In addition, COPDPredict™ offers you a suite of digital educational material on healthy living, inhaler technique and pulmonary rehabilitation to help you self-manage your COPD and remain in control.
COPDPredict™ is registered with MHRA and is OWASP and DSP toolkit compliant.
NEPeSMO is a UK-registered healthcare technology company founded by respiratory physicians who have worked with patients and clinicians to develop and deliver smart user-friendly self-monitoring solutions for personalised respiratory care and treatment.
At the moment NEPeSMO interacts directly with healthcare providers to offer the COPDPredict™ service under a software-as-a-service agreement. If you are an individual living with COPD and experience exacerbations of COPD and wish to use COPDPredict, you can only do this if your healthcare team has signed up to our services and has registered you as a patient.
Please do contact us for further information on [email protected] or visit our website www.nepesmo.com where you can view what COPDPredict™ does and how it works.
Hide Show More...

Screenshots

COPDPredict FAQ

  • Is COPDPredict free?

    Yes, COPDPredict is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is COPDPredict legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does COPDPredict cost?

    COPDPredict is free.

  • What is COPDPredict revenue?

    To get estimated revenue of COPDPredict app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Finland yet.
Ratings History

COPDPredict Reviews

No Reviews in Finland
App doesn't have any reviews in Finland yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

COPDPredict Installs

Last 30 days

COPDPredict Revenue

Last 30 days

COPDPredict Revenue and Downloads

Gain valuable insights into COPDPredict performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.